N eural circuits consist of large populations of cell bodies connected by axons and dendrites. Understanding circuit computations (and even the computations of single neurons) requires knowing the neural representation carried by inputs, local neurons, and outputs that lead to input-output transformations. Axons are very thin (typically less than 1 μ m in diameter), branch numerous times, can vary in length, and travel the full extent of the brain, thus making activity-recording difficult. Microelectrodebased recording methods do not allow isolation of single axons and lack the genetic specificity required to identify the source of the recorded input signals. Genetically encoded calcium indicators (GECIs; for review, see ref. 1 ), such as the GCaMP family 2-5 , have enabled recordings from the somata and dendrites of genetically defined neuronal populations in behaving animals. However, optical recording from individual axons and presynaptic structures with GECIs is suboptimal, thus limiting comprehensive interrogation of afferent inputs.
In vivo calcium imaging from axons provides direct interrogation of afferent neural activity, informing the neural representations that a local circuit receives. Unlike in somata and dendrites, axonal recording of neural activity-both electrically and optically-has been difficult to achieve, thus preventing comprehensive understanding of neuronal circuit function. Here we developed an active transportation strategy to enrich GCaMP6, a genetically encoded calcium indicator, uniformly in axons with sufficient brightness, signal-to-noise ratio, and photostability to allow robust, structure-specific imaging of presynaptic activity in awake mice. Axon-targeted GCaMP6 enables frame-to-frame correlation for motion correction in axons and permits subcellular-resolution recording of axonal activity in previously inaccessible deep-brain areas. We used axon-targeted GCaMP6 to record layer-specific local afferents without contamination from somata or from intermingled dendrites in the cortex. We expect that axon-targeted GCaMP6 will facilitate new applications in investigating afferent signals relayed by genetically defined neuronal populations within and across specific brain regions.
increased nADR compared with GCaMP6m (nADR of GAP43-GCaMP6s, 5.65 ± 1.03; nADR of GAP43-GCaMP6f, 4.58 ± 0.44; P = 8.72 × 10 -5 and P = 2.19 × 10 -6 , respectively). In contrast, direct tethering to a presynaptic protein (i.e., Synaptophysin-GCaMP 15 or syGCaMP), as previously reported, only moderately targeted the probe to axons, producing about a twofold increase compared to u-GCaMP6m (nADR: 1.70 ± 0.11, P = 0.23). The GAP43-fused GCaMP6m showed rapid enrichment in axons as early as 2 d posttransfection, remained stable across 5 d ( Supplementary Fig. 1c ), and displayed more consistent labeling across axonal arbors than u-GCaMP6m or syGCaMP6m ( Supplementary Fig. 1d,e ). We refer to GAP43-fused GCaMP6 as 'axon-GCaMP6' and further characterized it in vivo.
We next sought to determine the targeting efficiency of axon-GCaMP6 in long-range axons in vivo. We engineered bicistronic constructs encoding either axon-GCaMP6s or u-GCaMP6s followed by a P2A peptide-fused untargeted red fluorophore (mRuby3) 26 , such that red fluorescence allowed normalization of expression levels ( Fig. 1d ). We labeled neurons in dorsal lateral geniculate nucleus of the thalamus (dLGN) with recombinant adeno-associated virus (rAAV) encoding axon-GCaMP6s-P2A-mRuby3 or u-GCaMP6s-P2A-mRuby3. We achieved similar patterns and levels of transduction of red fluorescence using both viruses ( Supplementary Figs. 2  and 3 ). Strikingly, in animals injected with axon-GCaMP6s-P2A-mRuby3, we found that somata and dendritic arbors of dLGN neurons were essentially devoid of green fluorescence after 2 weeks of expression, while the axons of this cell population were brightly labeled in primary visual cortex (V1; Fig. 1e ). To calculate nADR, we calculated the ratio of green fluorescence from dLGN axons in layer 4 (L4), the primary target of the dLGN axons within V1, to those from somata within dLGN and normalized them to the ratio of red fluorescence. Similarly to what we observed in dissociated neuronal culture, axon-GCaMP6s displayed about a fivefold increase to nADR over u-GCaMP6s (axon-GCaMP6s, 2.54 ± 0.28; u-GCaMP6s, 0.50 ± 0.06; P = 4.37 × 10 -16 ; Fig. 1f ). These data suggested that axon-GCaMP6s is actively transported into distal axons.
We then sought to characterize the photostability and diffusibility of axon-GCaMP6m using fluorescence loss in photobleaching Results were found to be consistent across three different cultures per construct. Scale bars, 20 μ m (insets); 100 μ m (cell traces). c, Normalized nADR (see Methods for description). Average nADRs of axon-GCaMP6m (4.83 ± 0.78) represent an approximate fivefold increase compared to u-GCaMP6m (0.76 ± 0.08) or syGCaMP6m (1.77 ± 0.11; F 2,27 = 26.52, P = 8.36 × 10 -7 , n.s. = 0.23, ****P = 3.09 × 10 -5 , respectively; one-way ANOVA with Tukey-Kramer multiple-comparisons test; n = 8-10 cells from three cultures for each construct). d-f, Characterization of nADR of thalamocortical axons in V1. (d) Schematic representation of viral injection site of AAV encoding bicistronic constructs in mouse dLGN. (e) Representative images showing densely labeled L4 axons projected from dLGN labeled with axon-GCaMP6s, whereas cell somata were nearly devoid of labeling. Results were consistent across four animals per construct. Scale bars, 100 μ m (cortex); 500 μ m (thalamus). (f) Probabilitydensity histogram (PDF) of nADR values derived for both constructs with medians indicated by vertical line (axon-GCaMP6s, 2.54 ± 0.28; u-GCaMP6s, 0.50 ± 0.06; P = 4.37 × 10 -16 ; Wilcoxon's rank-sum test; n = 56 slices for axon-GCaMP6s and n = 37 slices for u-GCaMP6s, from 3 animals per construct). Data are presented as mean ± s.e.m. and fluorescence recovery after photobleaching assays ( Fig. 2a,d and Supplementary Fig. 4a-e ). Axon-GCaMP6m diffused rapidly between adjacent axonal compartments at a rate similar to that of u-GCaMP6m (mobile fraction of axon-GCaMP6m, 0.77 ± 0.02; mobile fraction for u-GCaMP6m, 0.90 ± 0.03; Fig. 2b,c and Supplementary Fig. 4d,e ). High diffusibility led to fast replenishment of bleached molecules, thus greatly reducing effective photobleaching of axon-GCaMP6m ( Fig. 2e ). In contrast, syGCaMP6m displayed significantly reduced diffusibility, resulting in rapid photobleaching consistent with previous in vivo observations 16 (mobile fraction for syGCaMP6m, 0.28 ± 0.01; Fig. 2c ,e and Supplementary  Fig. 4c ). Additionally, the dipalmitoylation modification of axon-GCaMP6m provided better photostability than some of the other targeting motifs that contained either myristoylation domains (for example, Lck) or multiple binding sites for transport effectors (for example, myosin VI binding domain), which is consistent with previously reported results 27 (Supplementary Fig. 4c ).
To confirm that axon-GCaMP is more photostable in vivo, we labeled dLGN with rAAV encoding u-GCaMP6s, syGCaMP6s, or axon-GCaMP6s ( Fig. 2f ), followed by continuous two-photon (b) Representative pseudo-linescans from u-GCaMP6m, axon-GCaMP6m, and syGCaMP6m FRAP demonstrated rapid recovery of fluorescence for u-GCaMP6m and axon-GCaMP6m, but not for syGCaMP6m. Experiment was repeated on two independent cultures per construct with similar results. (c) Mobile fractions of u-GCaMP6m, syGCaMP6m, and axon-GCaMP6m as assessed by FRAP (χ 2 2,11 = 9.85, P = 0.0073, n.s. = 0.26, **P = 0.0048, respectively; Kruskal-Wallis test with Dunn's test for multiple comparisons; n = 4 cells from 2 plates per construct). Data plotted as mean ± s.e.m. (e) Time course of normalized fluorescence intensity changes during FLIP experiments. Data plotted as mean (solid line) ± s.e.m. (shaded regions); n = 3 cells per construct. f,g, Characterization of photostability in vivo. (f) Schematic representation of viral injection in dLGN followed by in vivo imaging axons projecting to V1. (g) Time course of fluorescence intensity normalized to the first 50 s of acquisition during imaging of dLGN projection. Data plotted as mean (solid line) ± s.e.m. (shaded regions); n = 377, 70, and 236 for u-GCaMP6s, syGCaMP6s, and axon-GCaMP6s, respectively. Individual traces were smoothed by a 100-timepoint boxcar filter to emphasize low-frequency components of data. h, Top: schematic representation of bicistronic constructs expressed in dissociated neuronal culture. Bottom: representative images showing increased green fluorescence in axons when labeled with axon-GCaMP6s, whereas u-GCaMP6s primarily labels somatodendritic compartments of neurons. Experimental data was derived from 3 independent cultures per construct with similar results. Scale bars, 10 μ m (somatic image), 3 μ m (axonal image). i,j, Average (i) Δ F/F and (j) SNR in response to indicated number of field-potential stimuli. Inset: reduced baseline noise in singletrial time-lapse traces of axon-GCaMP6s in response to 20 field potential stimuli. Data plotted as mean peak values ± s.d.; n = 9 imaging sessions from 3 transductions per construct.
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Time (s) r 1 = corr(F(x,y,t 1 ),F(x,y,t 2 )) r n -1 = corr(F(x,y,t n -1 ),F(x,y,t n )) Normalized average frame-to-frame correlation Normalized average frame-to-frame correlation u-GCaMP6s axon-GCaMP6s excitation through a cranial window in awake, behaving animals. Upon hundreds of seconds of illumination, the fluorescence of dLGN projections in superficial V1 labeled with either u-GCaMP6s or axon-GCaMP6s remained largely unchanged ( Fig. 2g and Supplementary Fig. 4f ). In contrast, the fluorescence signals of syG-CaMP6s-labeled projections decreased by more than 50% during the initial 400 s of illumination ( Fig. 2g and Supplementary Fig. 4f ). Finally, we characterized the sensitivity of axon-GCaMP6 in response to field-potential stimuli. We transfected axon-GCaMP6s-P2A-mRuby3 or u-GCaMP6s-P2A-mRuby3 into cultured hippocampal neurons. After 5 d of expression in dissociated neuronal culture, the ratio of green-to-red fluorescence of axons expressing axon-GCaMP6s was about fivefold higher than those labeled with u-GCaMP6s (axon-GCaMP6s, 0.100; u-GCaMP6s, 0.023; Fig. 2h and Supplementary Fig. 5a ). In response to a variety of field-potential stimuli (30 Hz), fluorescence changes (Δ F/F 0 ) of axon-GCaMP6s were similar to those of u-GCaMP6s, with higher basal fluorescence levels ( Supplementary Fig. 5b ) and lower noise, resulting in ~twofold enhancement in SNR (for details, see Methods) across all stimuli (Fig. 2i,j and Supplementary  Fig. 5b ). Kinetics ( Supplementary Fig. 5c,d ), size of detected regions of interest (ROIs, ~ 0.5-10 µ m 2 ) 28 ( Supplementary  Fig. 5e ,f), and fluorescence brightness from the secondary fluorophore, mRuby3 ( Supplementary Fig. 5g,h) , were similar between axon-GCaMP6s and u-GCaMP6s. We therefore conclude that increased probe enrichment in axons was the primary driver of the observed enhancement to SNR displayed by axon-GCaMP6s.
In vivo imaging of distal afferent calcium signals with axon-GCaMPs. We sought to determine whether improved properties of axon-GCaMP6 could enable in vivo applications that are difficult with u-GCaMP. Thalamocortical projections to sensory cortices, such as those projected from dLGN and lateral posterior nucleus of the thalamus (LP), are dimly labeled by u-GCaMPs 9,11,12 .
To determine the effect of axonal enrichment on SNR, we stimulated mice with drifting gratings and imaged the responses of dLGN cells ( Supplementary Fig. 6d -f) at their axon terminals in layer 1 (L1) of V1.
We successfully recorded calcium signals in thalamocortical axons in superficial layer of V1 in response to drifting grating stimuli 11, 12 ( Fig. 3c,h ). Axons labeled with axon-GCaMP6s displayed a ~sevenfold increase in normalized basal green fluorescence over u-GCaMP6s for dLGN axons (5.86 for axon-GCAMP6s, 0.85 for u-GCaMP6s; P = 2.15 × 10 -259 ). LP axons similarly showed a ~fourfold increase (19.47 for axon-GCaMP6s, 5.08 for u-GCaMP6s; P = 1.24 × 10 -319 ; Fig. 3b ,e,g,j and Supplementary Video 1). While u-GCamP6sexpressing axons displayed bright fluorescent varicosities that are likely boutons 6, 7, 29 , axon-GCaMP6s fluorescence was relatively homogenous in both axonal shafts and varicosities ( Fig. 3b ,g). Because signal amplitude is generally lower in the axonal shaft than in varicose structures ( Supplementary Fig. 7 ; see also ref. 29 ), we drew ROIs over varicosities (for details, see Methods) and measured visual responses of thalamocortical axonal populations. SNR (for details, see Methods) of axon-GCaMP6s in response to drifting gratings was significantly improved for dLGN axons (2.73 for axon-GCAMP6s, 1.54 for u-GCaMP6s; P = 9.56 × 10 -130 ) as well as LP axons (1.57 for axon-GCaMP6s, 0.98 for u-GCaMP6s; P = 1.13 × 10 -95 ; Fig. 3d ,e,i,j). Consistent with our dissociated neuronal culture data, similar Δ F/F 0 values were observed across both constructs for dLGN axons (0.72 for axon-GCAMP6s, 0.40 for u-GCaMP6s; P = 5.41 × 10 -73 ) and LP axons (0.86 for axon-GCaMP6s, 0.83 for u-GCaMP6s; P = 0.44; Supplementary Fig. 6b ,c,e,f).
We next compared the sensitivity of axon-GCaMP6s with syGCaMP6s. Because syGCaMP6s bleaches more rapidly than other GCaMP6s designs (Supplementary Figs. 4f and 8a-c), we observed trial-number-dependent rundown of ∆ F/F and SNR values ( Supplementary Fig. 8c-e ). We then compared the brightness of ROIs only in the first 25 s of imaging. At this early period of the imaging session, brightness of axon-GCaMP6s was less than twofold higher than that of syGCaMP6s (5.57 for axon-GCaMP6s, 3.45 for syGCaMP6s; P = 3.13 × 10 -19 ; Supplementary Fig. 8f ,g). When averaged across all trials, syGCaMP6s exhibited comparable Δ F/F values (0.72 for axon-GCaMP6s, 0.65 for syGCaMP6s; P = 0.016) and significantly lower SNRs (2.73 for axon-GCaMP6s, 1.63 for syGCaMP6s; P = 1.14 × 10 -25 ) than axon-GCaMP6s ( Supplementary  Fig. 8h-k) .
In addition, we examined axonal enrichment and SNR of GCaMP6f when fused to the GAP43 targeting motif. As expected, we observed a ninefold increase in normalized basal green fluorescence (5.99 for axon-GCaMP6f, 0.60 for u-GCaMP6f; P = 9.87 × 10 -98 ) and a 1.5-fold increase in SNR over u-GCaMP6f for dLGN axons (1.27 for axon-GCaMP6f, 0.78 for u-GCaMP6f; P = 1.20 × 10 -9 , Kolmogorov-Smirnov test; Supplementary Fig. 9 ).
We did not observe significant differences in population orientation or direction preference between axon-GCaMP6s-and u-GCaMP6s-labeled thalamocortical axons (F 1, 275 = 0.001, P = 0.97; Supplementary Fig. 10a-f ). Further, the response kinetics was not perturbed beyond what would be expected for higher levels of GCaMP indicator expression 30 ( Supplementary Fig. 10g -i). Together, these data suggest that axon-GCaMP6s expression did not alter neuronal physiology. Our data thus show that axon-GCaMP6s enriches in long-range axons, resulting in enhanced SNR in vivo without interfering with circuit properties.
Axon-GCaMP6 can also be efficiently expressed in short, corticocortical projections at early timepoints following viral induction, when u-GCaMP is only minimally expressed ( Supplementary Fig. 11a ). Two weeks after injection of u-GCaMP6s or axon-GCaMP6s virus into lateromedial (LM) visual cortex, we observed minimal expression of u-GCaMP6s in LM axons in V1, and only 20% of analyzed ROIs were visually responsive. In contrast, axon-GCaMP6s enriched in axons, displaying bright axonal and bouton labeling, with 80% of axons responding to visual stimuli. The SNR was increased threefold (1.09 for axon-GCaMP6s, 0.35 for u-GCaMP6s; P = 5.62 × 10 -12 ), while ∆ F/F 0 showed a twofold improvement (0.65 for axon-GCaMP6s, 0.30 for u-GCaMP6s; P = 1.06 × 10 -7 ; Supplementary Fig. 11 ), suggesting that active transportation of axon-GCaMP6 allows imaging at earlier timepoints in axons.
The enhanced brightness and photostability offered by axon-GCaMP6 permitted robust cross-correlation-based correction of motion artifacts in axonal structures ( Fig. 3k-m ). Motion artifacts plague imaging experiments in awake, behaving animals, but are usually correctable (at least in part) with brightly labeled cell bodies. Image registration in axons is especially challenging if the axons are only dimly labeled, particularly as axons are tiny and can easily move within the imaging plane. These difficulties are especially pronounced at commonly used acquisition speeds, leading to limited photon budgets and poorly defined structural information for performing motion correction. As such, axonal motion artifacts are frequently uncorrectable. The increased brightness and photostability of axon-GCaMP6s at distal axons ( Fig. 3b ,e,g,j and Supplementary Fig. 11b ,f) greatly increased frame-to-frame correlations relative to u-GCaMP6s (five-to tenfold; correlations normalized to uGCaMP6s: dLGN axons, 4.83; LP axons, 4.76; LM axons, 10.41; Fig. 3k -m and Supplementary Fig. 11e ), allowing efficient motion-artifact correction in axonal structures 31 .
Axon-GCaMP enables imaging of thalamic boutons in deep cortical layers in vivo.
The small size and dim fluorescence of axons and boutons similarly presents difficulties for imaging deep structures, such as in the subgranular layers of cortex. Even with adaptive optics, tuning properties of thalamic axons are difficult to obtain more than 400 μ m below the pia using u-GCaMP6s 11 . As a comparison, boutons of axons projecting from dLGN to the supra-and subgranular layers of V1 were imaged with u-GCaMP6s and axon-GCaMP6s in headfixed, awake mice. Average fluorescence intensity was recorded in 100-μ m bins down to 500 μ m below pia and normalized to the square of the excitation laser power (Fig. 4a,b ). Axon-GCaMP6s was brighter (Fig. 4b ) while providing better contrast ( Supplementary  Fig. 12 ) than u-GCaMP6s at all depths. This enhanced brightness facilitated the first recordings of dLGN L5/6 axons at depths down to 600 μ m ( Fig. 4c-e ). Orientation-specific fluorescence transients (∆ F/F 0 ) were clearly observable, and from these transients, we calculated orientation tuning curves of these deep cortical axons ( Fig. 4c-e ). Similarly, axon-GCaMP6f was also brighter at all depths than u-GCaMP6f. Especially at 600 μ m, axon-GCaMP6f allowed for effective recordings of orientation-specific tuning, whereas no fluorescence signal sources were observable with u-GCaMP6f ( Supplementary Fig. 13 ). Thus, axon-GCaMP6 allows in vivo interrogation of previously inaccessible axons deep within tissue.
Axon-GCaMP enables layer-specific imaging of local afferents in vivo. Lastly, we used a Cre-dependent axon-GCaMP6 to record orientation and direction tuning of axons projecting from L4 V1 neurons in each recipient cortical layer without contamination of signal from somatodendritic sources (Fig. 5 ). L4 excitatory neurons were labeled in Scnn1a-Tg3-Cre mice using rAAV encoding FLEx-axon-GCaMP6s-P2A-mRuby3 or FLEx-GCaMP6s-P2A-mRuby3 driven by the human Synapsin1 promoter (Fig. 5a,b ). Three weeks after infection, we observed L4 axons labeled with axon-GCaMP6s ramifying across all cortical layers, whereas u-GCaMP6s primarily labeled the somatodendritic compartments of L4 neurons (Fig. 5c ). L4 axons and boutons were easily identifiable from intermingled dendritic structures within different cortical layers (Fig. 5c ). The average green-to-red ratio of axon-GCaMP6s in axons was about fivefold higher than that of u-GCaMP6s (axon-GCaMP6s, 2.25; u-GCaMP6s, 0.53; P < 4.94 × 10 -
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; Fig. 5d ). In contrast, the green-to-red ratio of axon-GCaMP6s in dendrites was sixfold lower compared to u-GCaMP6s, indicating specific axonal enrichment of axon-GCaMP6s (axon-GCaMP6s, 0.21; u-GCaMP6s, 1.24; P = 1.57 × 10 -26 ; Fig. 5e ).
In agreement with our histological results, no dendritic structures were observed in the in vivo two-photon fields of view ( Fig. 5f and Supplementary Fig. 14a ). In contrast, animals transduced by u-GCaMP6 showed numerous intermingled dendritic structures ( Supplementary Fig. 14b ). Using axon-GCaMP6s, we were able to readily detect the response (Fig. 5g-i) and calculate the orientationtuning properties of individual boutons from L4 neurons throughout their projection fields across cortical depths down to 600 μ m ( Fig. 5i and Supplementary Fig. 15 ).
In addition, axon-GCaMP6s permits layer-specific output recording of axons projected from other cortical layers as well. When rAAV-hSynapsin-FLEx-axon-GCaMP6s was introduced to V1 of Rbp4-Cre or Ntsr1-Cre driver mouse lines to restrict expression to L5 or L6, respectively, single-bouton tuning properties were clearly detectable in their recipient layers ( Supplementary Fig. 14) . Thus, axon-GCaMP6s permits recordings of local afferents down to individual boutons even when dendritic structures of transduced cells are present within the same tissue volume.
Discussion
We have overcome the limitations of genetically encoded calcium indicators to allow robust imaging of afferent calcium transients deep in tissue, with structural specificity and with greater SNR. We achieved this by creating an axon-targeted GECI, axon-GCaMP6, which enriches exclusively in local or distal axons with enhanced brightness and photostability, thus expanding calcium imaging beyond the soma and dendrites. Although presynaptic-targeted GCaMPs, such as syGCaMP6, have been developed, imaging with sensors that localize tightly to presynaptic compartments suffers substantially from photobleaching (Fig. 2g) . In contrast, axon-GCaMP6 is diffusible, photostable, and displays enhanced SNR. The enrichment of axon-GCaMP6 in axons offers enhanced frameto-frame cross-correlation without extensive averaging, which greatly facilitates motion correction of axons in vivo.
Axon-GCaMPs enable new applications of calcium imaging with subcellular resolution noninvasively in deep cortical lay-ers. Thalamic axons ramify in both supra-and subgranular layers. However, in vivo calcium imaging of thalamic boutons has been limited to superficial layers (< 400 µ m below pia) with untargeted GCaMP6s or GCaMP6f, even with the aid of adaptive optics. With axon-GCaMP6s and axon-GCaMP6f, the tuning properties of individual thalamocortical boutons in subgranular layers can be readily imaged without the aid of adaptive optics while preserving good SNR, which we expect will open the door for new studies of longrange communication in deeper tissue. As an example application, it is now established that infragranular layers, including L5 32,33 and L6 34 , receive direct thalamocortical innervation from primary thalamic nuclei. Previous methods have left the axons that form these connections functionally inaccessible. Deeper imaging made possible by axon-GCaMP6 will alleviate this methodological gap.
Finally, we used axon-GCaMP6 to record orientation tuning and direction tuning of layer-specific axonal inputs projected from local neurons, while excluding signal from their extensively intermingled dendritic structures. Recording from local axonal inputs with layer specificity remained difficult, largely due to contamination from intermingled dendritic structures. Generally, it remains unclear what information is provided by local afferents on a layer-by-layer basis. Axon-GCaMP6 allows direct interrogation of these signals with requisite spatial resolution while avoiding contaminating signal from transduced dendrites.
Long-term, high-level expression of GECIs in the mouse brain can result in prolonged response or nonfunctional indicators and can perturb circuit function. In the case of axon-GCaMP6, the enrichment in axons did not perturb neuronal physiology, as evidenced by kinetics and properties of orientation tuning remaining similar to those of untargeted GCaMP6 after long-term expression (4-6 weeks). Although we did not observe adverse effects in our experiments, physiological impact should be carefully examined in each experimental preparation. Possible interference with synaptic physiology should also be examined.
Axon-GCaMP will be useful in a number of other applications and brain regions, and the targeting tag might be transferable to other payloads. The axonal targeting sequence is only 20 amino acids, allowing easy fusion with both red-shifted 35, 36 and Förster resonance energy transfer-based GECIs [37] [38] [39] [40] [41] or other genetically encoded sensors of neural activity, such as neurotransmitter sensors 42 . Axonal enrichment may be particularly useful for red indicators, as this approach enhances brightness in small subcellular compartments without extensive optimization of basal fluorescence of the indicator itself. In addition, it may be possible to target actuators 43 to axons to allow axon-specific activation of input signals.
Though axon-GCaMP6 is a superior tool for afferent imaging in the mammalian brain, axon-GCaMP6 is not intended as a replacement for monitoring synaptic calcium using syGCaMP. Indeed, syGCaMP indicators have proven their utility for uncovering the coupling between presynaptic calcium and vesicular release in dissociated neuronal cultures 44, 45 , flies 46 , and larval zebrafish 47 . It has also been used to address systems-level questions in the more optically accessible larval zebrafish 48, 49 . However, in mouse brain, we observed a high degree of photobleaching of syGCaMP ( Fig.  2g) , which precludes imaging for longer than a few minutes. When expressed in dissociated neurons, syGCaMP displayed significantly reduced diffusibility (P = 0.0048; Fig. 2c ), limiting replenishment of photobleached molecules in boutons. The fast photobleaching in vivo is therefore presumably due to slow replenishment of bleached molecules into the imaged volume during prolonged imaging experiments. As the axon-GCaMP targeting strategy maintains fast diffusibility, it is more photostable than syGCaMP6 both in vitro and in vivo.
In vivo, axon-GCaMP6 reports axonal calcium transients in both axonal shafts and putative boutons more effectively than u-GCaMP6. We also observed that fluorescence responses of axon-GCaMP6 in shafts were smaller than those in putative boutons ( Supplementary Fig. 7) , consistent with previous observations that calcium signals in axons concentrate in the proximity of boutons (see also refs 29, 50 ). When combined with post hoc structural analysis, it is possible to delineate calcium signals originating in axon shafts or putative boutons. However, when recording afferent signals from specific axons in vivo, interest is often focused on information encoded by axonal signals. Therefore, differentiating signals at synapses versus axons does not usually add additional information for answering questions at the systems level. Axon-GCaMP6 allows more effective analysis of Ca 2+ signals within axonal shaft compartments, which exhibit signals that are highly correlated with those found in boutons of the same axon 6, 14 . As axonal imaging becomes a rich area of research, requiring calcium indicators that are photostable, bright, and capable of specifically reporting axonal signals, we expect that this specialized GCaMP6 will greatly facilitate recordings from afferent signals of any length with subcellular resolution.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0211-4.
Protein engineering. All constructs were designed using a combination of overlap extension cloning and gBlock gene fragments (Integrated DNA Technologies). All constructs were flanked by BamHI with a downstream Kozak sequence and start codons, as well as HindIII for final subcloning onto pAAV-hSynapsin1 vectors. Alternatively, constructs were flanked by SacI and AflII sites for subcloning into custom pAAV-hSynapsin1-FLEx vectors.
Concurrent two-color fluorophore expression was achieved by the use of either two plasmids with mRuby2 as the red reference fluorophore or a bicistronic approach in which the GCaMP construct was separated by a P2A sequence 51 from a downstream mRuby3. The two-plasmid approach was used for all in vitro characterization, while the bicistronic approach was used for in vivo characterization. Functional assays were performed with no reference fluorophore.
Dissociated hippocampal neuronal culture. For ADR and diffusion analyses, primary hippocampal neuronal cultures were prepared as described previously 3 . Briefly, P0 or E18 pups were decapitated, and the brains were dissected into icecold neural dissection solution (NDS, 10 mM HEPES (Sigma) in Hank's Balanced Salt Solution (HBSS, Thermo Fisher Scientific), pH 7.4). Hippocampi were removed, enzymatically digested with papain (~ 60 units), washed with prewarmed plating medium (PM, Minimal Essential Medium (Thermo Fisher Scientific) supplemented by 10% FBS (Thermo Fisher Scientific) and 100 U/mL penicillin-streptomycin (Thermo-Fisher Scientific)) and then mechanically digested by trituration. Cells were plated on 35 mm MatTek glass bottom dishes (MatTek) coated with Matrigel matrix (BD Biosciences) or a mixture of poly-lornithine (Sigma-Aldrich) and laminin (Sigma-Aldrich), and kept at 37 °C, 5% CO 2 in PM for ~ 24 h and then in Neurobasal medium (Thermo Fisher Scientific) supplemented by 10% B27 (Thermo Fisher Scientific) for the experiment duration, with half medium exchanges every 4 d. On the fifth day in vitro (DIV), cells used for ADR and FRAP/FLIP experiments were transfected by Effectene (Qiagen), following the manufacturer's recommendations with the following modification: for 100 μ L transfection complex, we included only 5 μ L Effectene reagent. Such cells were subsequently used for imaging experiments between 2 and 5 d post-transfection. Cells used for SNR analysis were transduced on DIV5 by rAAV-hSynapsin-GCaMP6s-P2A-mRuby3-WPRE-SV40 or rAAV-hSyanspin-axon-GCaMP6s-P2A-mRuby3-WPRE-SV40 to drive near-complete transduction of all cultured neurons. All cultures were imaged on a laser scanning confocal microscope (Zeiss 710) equipped with 405-, 488-, 514-, 561-, and 633-nm laser lines. Band limits for detection of GCaMP fluorescence were set between 493 and 541 nm while collection of mRuby fluorescence was beyond 590 nm. Prior to imaging, cultures were washed and incubated in HBSS containing 2 mM MgCl 2 and CaCl 2 to minimize background due to fluorescent culture medium components. For experiments requiring field stimulation, an RC-37FS perfusion insert (Warner Instruments) was fitted into the MatTek. During such experiments, spontaneous network activity was suppressed by inclusion of 20 μ M of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 40 μ M of d-(-)-2-amino-5-phosphopentanoic acid (D-APV) to the imaging medium. All data collected for quantitative comparisons were collected with identical imaging parameters, except that the laser power was adjusted to just below saturation for the brightest feature of the imaged cell or fields.
Quantification of axon-to-dendrite ratio. Calculation of the normalized ratio was performed following the method of Lewis et al. 25 . Specifically, a non-normalized ratio of fluorescence between the axon and somatodendritic compartments was calculated as
where F TestFP refers to the background-subtracted average fluorescence of GCaMP within the indicated structure. This measure was then normalized to similar values for mRuby2 as
where F refPF refers to the background-subtracted average fluorescence of mRuby2 within the indicated structure. Normalizing to the distribution of red fluorescence thus controls for differences in diffusivity across different cells.
Fluorescence loss in photobleaching and fluorescence recovery after photobleaching. For FLIP experiments, axonal segments greater than 100 μ m from the soma were targeted for imaging. After a baseline of ten images, images were acquired alternating with application of bleaching pulses over a 10-μ m circle centered in the imaged frame. The same 488-nm line from a 25-mW argon laser was used as the bleaching excitation with a pixel dwell time of 1.58 μ s. Loss of fluorescence was then tracked within a background-subtracted ROI covering the axon within the bleached circle. For these experiments, all fields of view included an axon that was not directly attached to the bleached segment. Fluorescence within this control axon segment was monitored to ensure that imaging did not cause greater than a 5% decrease in baseline fluorescence. Imaging sessions in which the control process fluorescence dropped by greater than this threshold were discarded. FRAP was also performed to extract diffusion coefficients of axonal GCaMP variants 52 . Imaging and bleaching parameters were identical to those used in the FLIP experiments, except that a single bleaching pulse was applied. To drive sufficient bleaching, experiments were conducted in imaging medium supplemented by 5 μ M of the calcium ionophore ionomycin, effectively increasing the extinction coefficient of the GCaMP 5 . Normalized postbleach profiles, f Postbleach (x), were determined by dividing the fluorescence profile directly following the bleaching epoch by that preceding the bleach event. Diffusion occurring between consecutive imaging acquisitions was then corrected for by fitting the effective bleach radius, r e , and bleach depth, K, of the normalized bleach profile to the equation FRAP curves were then determined by fitting the recovery time course, F(t), to the equation
where a, F 0 , F ∞ , τ slow and τ fast are free parameters corresponding to the double exponential fraction, the initial postbleach fluorescence, the steady-state fluorescence recovery level, and the slow and fast exponential recovery rates, respectively. The time to half recovery, t ½ , was then determined as the timepoint where = ∕ − ∞ F t ( ) Characterization of performance in dissociated neuronal culture. To quantify performance of GCaMP-labeled cell culture, we performed electrical fieldstimulation experiments in dissociated hippocampal culture. In cultures densely transduced by virus, confocal imaging was performed on intermingled fields of axons within fields of view more than 100 μ m from the nearest visible dendritic segment. Axons imaged for this study were first masked using the mRuby3 fluorescence signal. These masks were segmented using an ICY plugin to split ROI 28 into ROIs with normal distribution and mean size around that of typical ROIs used in in vivo imaging experiments (0.8-10 μ m 2 ). Time-lapse calcium imaging stacks were acquired from these axons based on the GCaMP fluorescence signal. After a 5-s baseline, 1, 2, 5, 10, 20, 40, or 80 field potentials were applied as 1-V, 1-ms square-wave pulses at 30 Hz under the control of Ephus software 53 . mRuby3-based ROIs were then analyzed with the average of the baseline period, F 0 , used to calculate the fluorescent transients Δ F/F 0 , as Δ F/F 0 = (F− F 0 )/F 0 . SNR was then calculated as the maximum Δ F/F 0 divided by the s.d. of the baseline period.
Animal procedures. All animal procedures were conducted according to the Portuguese Direcção Geral de Veterinária and the United States National Institutes of Health guidelines for animal research and were approved by the Institutional Animal Care and Use Committee at the University of California, Davis, the Howard Hughes Medical Institute, or the Champalimaud Center for the Unknown. Wild-type mice were used for in vivo functional imaging of visual thalamic axons as well as for LM corticocortical projections (older than P60, C57BL/6 J). Scnn1a-Tg3-Cre mice (Jax no. 009613), Rbp4-Cre mice (MMRRC no. 031125-UCD), and Ntsr1-Cre mice (MMRRC no. 030648-UCD) of both sexes (older than P60) were used for in vivo functional imaging of cortical afferents from L4, L5, and L6 neurons, respectively. Sample sizes (numbers of mice, cells and/or boutons) for each experiment are stated in main text.
Viral injections.
Injection procedures were essentially identical to those described in refs 6,11 with a few exceptions. Briefly, virus injection was performed using a glass pipette beveled at 45° with a 15-to 20-μ m opening and backfilled with mineral oil. A fitted plunger controlled by a hydraulic manipulator (Narashige, MO10; or World Precision Instruments, UMP3) was inserted into the pipette and used to load and inject the viral solution.
For confirmation of enhanced axonal expression of axon-GCaMP6s in living mice, ~ 20-40 nL of rAAV2/1-hSynapsin1-GCaMP6s-P2A-mRuby3-WPRE-SV40 (~ 2 × 10 13 viral genome (vg) per mL) or rAAV2/1-hSynapsin1-axon-GCaMP6sP2A-mRuby3-WPRE-SV40 (~ 3.2 × 10 13 vg per mL) were slowly injected into dLGN (2.1 mm posterior to bregma; 2.3 mm lateral from midline; 2.5 mm below pia). For axon-specific labeling of local cortical connections in V1, ~ 20-40 nL of rAAV2/1-hSynapsin1-axon-GCaMP6s-WPRE-SV40 (~ 1.2 × 10 13 vg per mL) were injected to cortical L4 (Scnn1a-Tg3-Cre mice: three injection sites in left hemisphere centered at 3.4 mm posterior to bregma; 2.7 mm lateral from midline; 0.3 mm below pia; injection sites are ~ 250 μ m apart). Additionally, we produced these viruses under a 2/5 serotype to test differences in transduction efficiency. We did not find apparent differences across serotypes (data not shown).
For calcium imaging of thalamocortical and LM corticocortical projections, ~ 20-80 nL of rAAV2/1-hSynapsin1-GCaMP6s-WPRE-SV40 (~ 2-4 × 10 13 infectious units per mL) or rAAV2/1-hSynapsin1-axon-GCaMP6s-WPRE-SV40 solution (~ 4 × 10 13 infectious units per mL) were slowly injected into dLGN, LP (1.9 mm posterior to bregma; 1.4 mm lateral from midline; 2.7 mm below bregma), or LM (coordinates determined by intrinsic optical imaging 54, 55 ). For imaging of cortical neurons and local axon projections ~ 20-40 nL of rAAV1-hSynapsin1-FLEx-GCaMP6s-WPRE-SV40 (~ 2.4 × 10 13 infectious units per mL) or rAAV1-hSynapsin1-FLEx-axon-GCaMP6s-WPRE-SV40 (~ 3.1 × 10 12 per mL) were injected per injection site into V1 for cortical L4 (Scnn1a-Tg3-Cre mice), cortical L5 (Rbp4-Cre mice), or cortical L6 (Ntsr1-Cre mice) for somatic or local cortical axon imaging, respectively, at three injection sites in left hemisphere centered at 3.4 mm posterior to bregma; 2.7 mm lateral from midline; 0.4 mm below pia; injection sites were ~ 250 μ m apart. All calcium imaging data of u-GCaMP6 + dLGN axons was first reported by Sun and co-workers 11 .
Head plate/cranial window implantation. Craniotomy and head plate implantation were carried out at the same time as virus injection for calcium imaging experiments. A 2.5-to 4-mm diameter craniotomy was made over the left V1 (center: 3.4 mm posterior to bregma; 2.7 mm lateral from midline) of the anaesthetized mice with dura left intact. For experiments using adaptive optical correction of aberration, 2 μ L of red fluorescent bead solution (2-μ m diameter; 1:500 in saline; Life Technologies, F-8826) was deposited on the dura surface. A glass window made of either a single coverslip (Fisher Scientific no. 1.5) or two coverslips bonded with ultraviolet-cured optical adhesives (Norland Optical Adhesives 61) was embedded in the craniotomy and sealed in place with cyanoacrylate. A titanium headpost was attached to the skull with cyanoacrylate glue and dental acrylic.
Visual stimulation. Visual stimuli were presented on a screen 13-17 cm distant at an angle of ~ 40° relative to the long axis of the animal on the contralateral side of imaged V1. The stimuli were composed of square gratings with 100% contrast, 0.04-0.07 cycles per degree, drifting at 26° s −1 , yielding a temporal frequency of ~ 2 Hz. For all projections, this stimulus was presented at 8 or 12 different orientations in a pseudorandom sequence. For dLGN recordings, stimuli were 12 s each, of which the stimulus was static for the first and last 3 s and drifted during the middle 6 s. For LP and LM recordings, baseline recordings were acquired for 2 s, during which a gray screen of mean intensity was presented, followed by a drifting grating for 2 s, and finally ending with 2-s presentation of the gray screen. A total of ten trials were presented for each stimulus orientation in the dLGN and LP recordings, and 20 trials were per orientation were presented for LM recordings.
Two-photon imaging. Imaging was performed with two-photon fluorescence microscopes 2-4 weeks after virus injection, when most neurons in dLGN, LP, and cortex exhibited nuclear-excluded expression 5 of GCaMP6s. Recording from LM axons were done 14-16 d after viral injection. For dLGN recordings, mice were headfixed, awake, and restrained. LP and LM recordings were taken in animals lightly anesthetized with 1% isoflurane and an intramuscular injection of chlorprothixene at 1 mg/kg during the imaging period. When imaging awake animals, mice were habituated to experimental handling by being headfixed onto the sample stage with its body restrained under a half-cylindrical cover 1 week after surgery. This procedure was repeated 3-4 times for each animal, and each time for 15-60 min. Each experimental session lasted between 45 min and 3 h. Multiple sections were imaged within the same mouse. GCaMP6 was excited at 900-940 nm with a Ti:sapphire laser (Ultra II, Coherent) or an optical parametric oscillator (InSight DeepSee, Spectra-physics) that was focused by either a Nikon 16 × , 0.8 NA or an Olympus 25 × , 1.05 NA objective. Emitted fluorescence photons were detected by a photomultiplier tube (H7422PA-40, Hamamatsu).
Axonal images from the brain surface down to up to 600 μ m below pia were acquired using custom LabView software or ScanImage5 53 . Images of thalamocortical and corticocortical axons in L1 were taken from 0-80 μ m below the pia. For comparison of depth characteristics of u-GCaMP6s and axon-GCaMP6s, imaging fields were binned at 100-μ m intervals down to a depth of 450 μ m. All imaging areas were confirmed to be in V1 by stereotactic coordinates Fixed tissue preparation. Following viral injection at timepoints specified within the main text, mice were deeply anaesthetized with isoflurane and transcardially perfused with PBS and then 4% paraformaldehyde (wt./vol.). Brains were removed and postfixed overnight in paraformaldehyde. Coronal brain slices were cut to 30-to 60-μ m thickness using a vibratome (V1200S, Leica) or cryostat (CM1860, Leica). Fluorescence images of these sectioned brains were acquired on a laser scanning confocal microscope (Zeiss LSM 710) equipped with 405-, 488-, 514-, 561-, and 633-nm excitation laser lines. Images were collected using the following Plan-Apochromat objectives: 10 × , 0.45 NA (optical section step of 2 μ m); 20 × , 0.8 NA (optical section step of 1.0 μ m); 40 × , 1.3 NA oil immersion (optical section step of 0.5 μ m); and 63 × , 1.4 NA oil immersion (optical section step of 0.5 μ m). For all calculations of ADR, images were first acquired in the somatic field with laser power set at a level just below saturation of all features in each channel. These same settings were applied during image acquisition in the axonal fields. nADR was then calculated as described in the section "Quantification of dendrite to axon ratio, " with somata from an entire slice used as the somatic component and L4 axonal projections used as the axonal component.
In vivo image analysis. Lateral motion artifact in two-photon imaging stacks was corrected using a cross-correlation-based registration algorithm 31 , where cross-correlation was used to determine translational shifts in images. In each image stack, the mean projection was used as the registration reference. Several rounds of registration and re-averaging of the stack were performed to decrease
where Δ x k and Δ y k represent the horizontal and vertical shifts of the kth image, respectively. This process was repeated once for LP and LM data and for up to seven iterations for the dLGN 11 data.
ROI selection. In average or s.d. images of registered image stacks, labeled axons appeared as bright spots in u-GCaMP6 and as filled axonal shafts and varicosities in axon-GCaMP6. For analysis of both u-GCaMP6 and axon-GCaMP6 experiments, circular ROIs (0.8-4 μ m 2 ) were manually drawn over varicosities that likely correspond to presynaptic boutons 11, 29 .
Characterizing ∆ F/F and SNR in vivo. For stacks derived from LP and LM axons, F 0 was calculated as the average of the baseline fluorescence for each stimulus presentation. For dLGN axons, the mode of the fluorescence intensity histogram from each ROI was used as F 0 . Fluorescence transients were then calculated as Δ F/F 0 = (F− F 0 )/ F 0 . Averaged Δ F/F 0 traces were then derived from the mean across ten trials of the same orientation. Resultant traces were then averaged over the period of stimulus presentation to derive a Δ F/F 0 value for each ROI. The s.d. of the Δ F/F 0 signal during the period before presenting the moving visual stimulus was calculated across trials, and the resultant values were averaged together. SNR was calculated by dividing the Δ F/F 0 value by the s.d.
To characterize the tuning properties of axonal boutons, we followed the previously described procedure 11 . Briefly, the response R of each ROI to a visual stimulus was defined as the average Δ F/F 0 across the window of drifting gratings. Here θ pref is the preferred orientation, R offset is a constant offset, and R pref and R oppo are the responses at θ pref and θ pref -180 degrees, respectively. ang(x) = min(x, x− 360, x + 360) wraps angular values onto the interval 0° to 180°. For the dLGN data, only ROIs whose tuning curves were well fit by the bimodal Gaussian function were considered orientation selective. In LP and LM data, ROIs were considered visually responsive if a two-sided t test between the fluorescence values during the baseline and stimulus period resulted in significance at an alpha value of 0.001.
For determining the frame-to-frame correlations, we calculated the 2-D correlation between frames of registered image stacks using the Matlab function corr2. The brightness of imaged varicosities from the dLGN thalamocortical projections was determined by normalizing pixel fluorescence value to the square of the excitation laser intensity 57 . Contrast was then determined by taking profiles across axonal structures and normalizing these profiles to the peak intensity.
Statistical methods. All statistical analyses were performed in Matlab (MathWorks) or Prism (GraphPad). We used parametric and nonparametric ANOVA, Wilcoxon's rank-sum tests, and Kolmogorov-Smirnov test. All tests were two-tailed. Error bars are s.e.m. or s.d., as indicated in figure legends and main text. No statistical methods were used to predetermine sample size. However, sample sizes are consistent with those reported in previous publications 31, 55 . Data collection was randomized in the organization of the experimental conditions and visual stimulus presentations. Data collection and analysis were not performed blind to the condition of the experiments. Data distribution was assumed to be normal, but this was not formally tested. No animals and no data points were excluded from the analyses.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article.
Data, reagent and code availability. The data that support the findings of this study are presented in the paper and the supplementary materials and all raw imaging data are available upon request. All routine analysis methods are included in the Methods section, and Matlab codes are deposited in GitHub (https://github. com/gerardj-broussard/BroussardEtAl2018.git). Plasmids encoding axon-GCaMP and bicistronic variants (accession numbers: MH282423, MH282424, MH282425, MH282426, MH282427, MH282429, MH282430, MH282432) have been made available in the Addgene plasmid repository (plasmid numbers 111261-112010).
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